Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients

por Wong, S C C, Ng, S S M, Cheung, M T, Luk, L Y, Chan, C M L, Cheung, A H K, Lee, V H M, Lai, P B S, Ma, B B Y, Hui, E P, Lam, M Y Y, Au, T C C, Chan, A T C
Publicado 2011

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells

por Comamala, M, Pinard, M, Thériault, C, Matte, I, Albert, A, Boivin, M, Beaudin, J, Piché, A, Rancourt, C
Publicado 2011

High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

por Mauland, K K, Trovik, J, Wik, E, Raeder, M B, Njølstad, T S, Stefansson, I M, Øyan, A M, Kalland, K H, Bjørge, T, Akslen, L A, Salvesen, H B
Publicado 2011

Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study

por Nørgaard, M, Farkas, D K, Pedersen, L, Erichsen, R, de la Cour, Z D, Gregersen, H, Sørensen, H T
Publicado 2011

Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1α-mediated apoptosis

por Khan, M N, Bhattacharyya, T, Andrikopoulos, P, Esteban, M A, Barod, R, Connor, T, Ashcroft, M, Maxwell, P H, Kiriakidis, S
Publicado 2011

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

por Stemmler, H J, diGioia, D, Freier, W, Tessen, H W, Gitsch, G, Jonat, W, Brugger, W, Kettner, E, Abenhardt, W, Tesch, H, Hurtz, H J, Rösel, S, Brudler, O, Heinemann, V
Publicado 2011

Multifunctional transcription factor TFII-I is an activator of BRCA1 function

por Tanikawa, M, Wada-Hiraike, O, Nakagawa, S, Shirane, A, Hiraike, H, Koyama, S, Miyamoto, Y, Sone, K, Tsuruga, T, Nagasaka, K, Matsumoto, Y, Ikeda, Y, Shoji, K, Oda, K, Fukuhara, H, Nakagawa, K, Kato, S, Yano, T, Taketani, Y
Publicado 2011

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis

por Duiker, E W, Meijer, A, van der Bilt, A R M, Meersma, G J, Kooi, N, van der Zee, A G J, de Vries, E G, de Jong, S
Publicado 2011

High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients

por Reuschenbach, M, Tran, T, Faulstich, F, Hartschuh, W, Vinokurova, S, Kloor, M, Krautkrämer, E, Zeier, M, von Knebel Doeberitz, M, Sommerer, C
Publicado 2011

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

por Yip, N C, Fombon, I S, Liu, P, Brown, S, Kannappan, V, Armesilla, A L, Xu, B, Cassidy, J, Darling, J L, Wang, W
Publicado 2011

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

por Uzoh, C C, Holly, J M P, Biernacka, K M, Persad, R A, Bahl, A, Gillatt, D, Perks, C M
Publicado 2011

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer

por Voss, M A, Gordon, N, Maloney, S, Ganesan, R, Ludeman, L, McCarthy, K, Gornall, R, Schaller, G, Wei, W, Berditchevski, F, Sundar, S
Publicado 2011

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

por Metcalfe, K, Gershman, S, Lynch, H T, Ghadirian, P, Tung, N, Kim-Sing, C, Olopade, O I, Domchek, S, McLennan, J, Eisen, A, Foulkes, W D, Rosen, B, Sun, P, Narod, S A
Publicado 2011

Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy

por Duanmu, J, Cheng, J, Xu, J, Booth, C J, Hu, Z
Publicado 2011

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches

por Lehmann-Che, J, Amira-Bouhidel, F, Turpin, E, Antoine, M, Soliman, H, Legres, L, Bocquet, C, Bernoud, R, Flandre, E, Varna, M, de Roquancourt, A, Plassa, L-F, Giacchetti, S, Espié, M, de Bazelaire, C, Cahen-Doidy, L, Bourstyn, E, Janin, A, de Thé, H, Bertheau, P
Publicado 2011

Prescription patterns of analgesics in the last 3 months of life: a retrospective analysis of 10202 lung cancer patients

por Gao, W, Gulliford, M, Higginson, I J
Publicado 2011

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

por Joensuu, H, De Braud, F, Grignagni, G, De Pas, T, Spitalieri, G, Coco, P, Spreafico, C, Boselli, S, Toffalorio, F, Bono, P, Jalava, T, Kappeler, C, Aglietta, M, Laurent, D, Casali, P G
Publicado 2011

Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer

por Kalimutho, M, Di Cecilia, S, Del Vecchio Blanco, G, Roviello, F, Sileri, P, Cretella, M, Formosa, A, Corso, G, Marrelli, D, Pallone, F, Federici, G, Bernardini, S
Publicado 2011

Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients

por Rawson, J B, Mrkonjic, M, Daftary, D, Dicks, E, Buchanan, D D, Younghusband, H B, Parfrey, P S, Young, J P, Pollett, A, Green, R C, Gallinger, S, McLaughlin, J R, Knight, J A, Bapat, B
Publicado 2011

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer

por Anderson, K S, Wong, J, D'Souza, G, Riemer, A B, Lorch, J, Haddad, R, Pai, S I, Longtine, J, McClean, M, LaBaer, J, Kelsey, K T, Posner, M
Publicado 2011